Literature DB >> 11113966

Treatment of antisocial personality, psychopathy, and other characterologic antisocial syndromes.

W H Reid1, C Gacono.   

Abstract

Treatment of antisocial personality disorder (APD) and ";core" psychopathy is usually considered a pessimistic clinical exercise. This paper reviews the importance of accurate diagnosis (including differences between APD and other antisocial syndromes), limited techniques for predicting and preventing adult antisocial syndromes, several kinds of treatment that have been attempted with varying success, management of specific antisocial behaviors, and the frustrations-even dangers-of working with severely antisocial patients. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh：

Year:  2000        PMID： 11113966     DOI： 10.1002/1099-0798(200010)18:5<647::aid-bsl407>3.0.co;2-o

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN： 0735-3936


  13 in total

1.  Neural correlates of impulsive aggressive behavior in subjects with a history of alcohol dependence.

Authors:  Samet Kose; Joel L Steinberg; F Gerard Moeller; Joshua L Gowin; Edward Zuniga; Zahra N Kamdar; Joy M Schmitz; Scott D Lane
Journal:  Behav Neurosci       Date:  2015-02-09       Impact factor: 1.912

2.  Antisocial behavioral syndromes and 3-year quality-of-life outcomes in United States adults.

Authors:  R B Goldstein; D A Dawson; S M Smith; B F Grant
Journal:  Acta Psychiatr Scand       Date:  2012-02-29       Impact factor: 6.392

3.  To treat a psychopath.

Authors:  Heidi L Maibom
Journal:  Theor Med Bioeth       Date:  2014-02

4.  Sex differences in antisocial personality disorder: results from the National Epidemiological Survey on Alcohol and Related Conditions.

Authors:  Analucia A Alegria; Carlos Blanco; Nancy M Petry; Andrew E Skodol; Shang-Min Liu; Bridget Grant; Deborah Hasin
Journal:  Personal Disord       Date:  2013-04-01

5.  THE RELATIONSHIP BETWEEN MALE-PERPETRATED INTERPARENTAL AGGRESSION, PATERNAL CHARACTERISTICS, AND CHILD PSYCHOSOCIAL FUNCTIONING.

Authors:  Jeniimarie Febres; Ryan C Shorey; Heather C Zucosky; Hope Brasfield; Michael Vitulano; JoAnna Elmquist; Andrew Ninnemann; Lindsay Labrecque; Gregory L Stuart
Journal:  J Child Fam Stud       Date:  2014-07-01

6.  Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Wilson M Compton; Attila J Pulay; W June Ruan; Roger P Pickering; Frederick S Stinson; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2007-04-12       Impact factor: 4.492

7.  Antisocial behavioral syndromes and past-year physical health among adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Deborah A Dawson; S Patricia Chou; W June Ruan; Tulshi D Saha; Roger P Pickering; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

8.  Three-year follow-up of syndromal antisocial behavior in adults: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2009-06-16       Impact factor: 4.384

9.  The Epidemiology of Antisocial Behavioral Syndromes in Adulthood: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Risë B Goldstein; S Patricia Chou; Tulshi D Saha; Sharon M Smith; Jeesun Jung; Haitao Zhang; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2017-01       Impact factor: 4.384

10.  Antisocial behavioral syndromes and body mass index among adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Deborah A Dawson; Frederick S Stinson; W June Ruan; S Patricia Chou; Roger P Pickering; Bridget F Grant
Journal:  Compr Psychiatry       Date:  2007-12-21       Impact factor: 3.735
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.